Search

Your search keyword '"Ke, Changwen"' showing total 345 results

Search Constraints

Start Over You searched for: Author "Ke, Changwen" Remove constraint Author: "Ke, Changwen" Search Limiters Full Text Remove constraint Search Limiters: Full Text
345 results on '"Ke, Changwen"'

Search Results

2. Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants

5. Iron Deficiency: Global Trends and Projections from 1990 to 2050.

7. Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants

8. Global Incidence of Diarrheal Diseases—An Update Using an Interpretable Predictive Model Based on XGBoost and SHAP: A Systematic Analysis.

11. Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China

12. Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids

13. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract

17. An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

18. Comparison of nonhuman primates identified the suitable model for COVID-19

19. Molecular Evolution, Diversity, and Adaptation of Influenza A(H7N9) Viruses in China

20. Influenza H5/H7 Virus Vaccination in Poultry and Reduction of Zoonotic Infections, Guangdong Province, China, 2017-18

24. Monitoring Avian Influenza Viruses from Chicken Carcasses Sold at Markets, China, 2016

25. Human infection with highly pathogenic avian influenza A(H7N9) virus, China

26. Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance

27. Progress of the COVID-19: Persistence, Effectiveness, and Immune Escape of the Neutralizing Antibody in Convalescent Serum

28. Effect of live poultry market interventions on influenza A(H7N9) virus, Guangdong, China

30. Human Fc-Conjugated Receptor Binding Domain-Based Recombinant Subunit Vaccines with Short Linker Induce Potent Neutralizing Antibodies against Multiple SARS-CoV-2 Variants

32. Characteristics of SARS-CoV-2 Delta variant-infected individuals with intermittently positive retest viral RNA after discharge

34. Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection

37. A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates

38. Association of GII.P16-GII.2 recombinant norovirus strain with increased norovirus outbreaks, Guangdong, China, 2016

41. Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants

42. Circulation of reassortant Influenza A(H7N9) viruses in poultry and humans, Guangdong Province, China, 2013

45. Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects

47. Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage

48. Socializing One Health: an innovative strategy to investigate social and behavioral risks of emerging viral threats

49. Metabolomic analyses reveal new stage-specific features of COVID-19

50. Correction to: Setting a baseline for global urban virome surveillance in sewage

Catalog

Books, media, physical & digital resources